medline.ch Onkologie Urologische Tumoren

	Web-Based Personalized Machine Learning Recommendations to Enhance Shared Decision-Making in Prostate-Specific Antigen Screening: Randomized Controlled Trial. JMIR Aging Lin YT, Huang YC, Liu CK, Cho HY, Chen M. PMID: 41973864 [PubMed - indexed for MEDLINE]
	First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France. Drugs Real World Outcomes Dourthe LM, Guillot A, Vassal C, Kazan E, Coeffic D, Rebischung C, Suau D, Lahouegue A, Aboulabbes S, Falabrègues A, Ould Lahsen H. PMID: 41973335 [PubMed - as supplied by publisher]
	[Update of S3Â guideline on metastatic prostate cancer-guideline recommendations and expert consensus]. Urologie Grimm MO, Gratzke C, Hadaschik B, Eiber M, Herrmann K, Hellmis E, Klier J, Kristiansen G, Wiedemann A, Merseburger A, Retz M, von Amsberg G. PMID: 41973209 [PubMed - as supplied by publisher]
	PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy? Ann Nucl Med Ibrahim EA. PMID: 41973167 [PubMed - as supplied by publisher]
	Screening for prostate cancer. J Med Screen Bestwick JP, Wald NJ. PMID: 41972986 [PubMed - as supplied by publisher]
	PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges. Cells Matsuoka T, Akamatsu S, Ong CJ, Gleave ME, Wang Y. PMID: 41972679 [PubMed - indexed for MEDLINE]
	Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic Therapy. Int J Urol Akagi N, Nagoshi A, Kubota M, Hagimoto H, Hattori Y, Makita N, Suzuki R, Suzuki I, Akahane M, Abe Y, Fukunaga A, Tohi Y, Kono Y, Matsumoto K, Matsuoka T, Tsutsumi N, Utsunomiya N, Shibasaki N, Kawakita M, Yamasaki T. PMID: 41972429 [PubMed - indexed for MEDLINE]
	Fungating Mass of the Glans Penis: A Case Report and Discussion on Penile Squamous Cell Carcinoma. J Investig Med High Impact Case Rep Collins DM, Simpkins AM, Diks J, Robertson D. PMID: 41972286 [PubMed - indexed for MEDLINE]
	Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application. Front Immunol Kagirova E, Enikeeva K, Mukhamadeev R, Asadullina D, Sharifyanova Y, Shmelkova P, Gainullina D, Trifonova D, Gattinger P, Docena G, Dubovets A, Tulaeva I, Karaulov A, Valenta R, Pavlov V. PMID: 41972142 [PubMed - indexed for MEDLINE]
	Objective value of the apparent diffusion coefficient (ADC) map from ultrahigh b-value diffusion-weighted imaging (DWI) in 3T MRI as a non-invasive predictor for Gleason score in prostate cancer. Quant Imaging Med Surg Zhang K, Chen Z, Zhang C, Wang M, Fu Y, Zhang Y, Hu Y, Shen Y, Ye H. PMID: 41972090 [PubMed]
	Efficacy of neoadjuvant hormonal therapy combined with robot-assisted radical prostatectomy for oligometastatic prostate cancer: a multicenter retrospective study. Front Oncol Dong Y, Li Z, Chen Z, Tian Z, Chen W, Hu J, Jia Y, Luo J, Zou N, Li J, Liu Q, Yang Q, Wang C, Xu X, Fu B, Zhang X, Wang B. PMID: 41971441 [PubMed]
	The mechanism of the PI3K-AKT-mTOR signaling pathway in renal cell carcinoma: current developments and future prospects. Front Oncol Zou C, Wang Y, Chen Q, Shi J, Wu X, Luo Q. PMID: 41971426 [PubMed]
	Performance enhancement method by using the probabilistic estimation for kidney tumor segmentation. Front Oncol Cheon W, Kim M, Han M, Lee SB, Shin D, Lim YK, Jeong JH, Chung Y, Kim H. PMID: 41971425 [PubMed]
	Development and validation of an MRI radiomics-based model for predicting progression risk in prostate cancer after endocrine therapy. Transl Androl Urol Ding K, Chen Q, Huang L, Huang R, Liu M, Gong M, Huang H. PMID: 41971132 [PubMed]
	Predicting inguinal lymph node metastasis in penile squamous cell carcinoma, from imaging, molecular biomarkers to multimodal AI: a narrative review. Transl Androl Urol Ahmad M, Shao Y, Gao Y, Hu X, Meng L, Cui H, Hanif S, Li X. PMID: 41971128 [PubMed]
	Radiomics and deep learning fusion model based on multiphasic CT for predicting HER2 expression status in bladder urothelial carcinoma: a multicenter study. Transl Androl Urol Pan W, Yang L, Yang L, Gu C, Lv Q, Zhang Y, Li M. PMID: 41971125 [PubMed]
	Comorbidity alterations between time for diagnosis and radical cystectomy in patients with muscle invasive bladder cancer undergoing neoadjuvant chemotherapy. Transl Androl Urol Oskarsson E, Johansson M, Lidén O, Alamdari F, Svensson J, Sherif A. PMID: 41971123 [PubMed]
	Development and validation of a clinical nomogram based on lasso-logistic regression for predicting prostate cancer with PSA 4-20.0 ng/mL: a retrospective study. Front Endocrinol (Lausanne) Ying M, Wang L, Yang M, Ke M, Sun L. PMID: 41970982 [PubMed - indexed for MEDLINE]
	Perioperative outcomes and postoperative functional outcomes of robot-assisted radical prostatectomy for oligometastatic versus localized prostate cancer: a multicenter matched case-control study. Gland Surg Dong Y, Li Z, Liu Y, Tian Z, Chen W, Chen Z, Jia Y, Luo J, Hu J, Zou N, Li J, Liu Q, Yang Q, Wang C, Xu X, Fu B, Zhang X, Wang B. PMID: 41969952 [PubMed]
	Development and feasibility assessment of an automated, synthetic CT-guided plan selection system for bladder cancer adaptive radiotherapy: a retrospective pilot study. Transl Cancer Res Meng H, Wang X, Liu P, Liu Q, Yang Y. PMID: 41969512 [PubMed]

Artikel 1 - 20 / 177466

Seite 1 von 8874

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung